IGF1 and isolated hemihyperplasia: During IHR post treatment, levels of IGF declined in all supplemented group exposed to IH compared to their RA counterparts, but supplementation with n-3 PUFAs resulted in higher serum IGF-I in both IH groups, compared to the RA controls (Figure 4B).